BRISTOL, Tenn. & ROCHESTER, Mich.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE: KG) and JHP Pharmaceuticals, LLC announced today the successful closing of an asset purchase agreement, pursuant to which JHP acquired King’s Rochester, Michigan sterile manufacturing facility, some of King’s legacy products that are manufactured there, and the related contract manufacturing business, for approximately $93 million in cash.
